Daniel Garza - Pure Harvest Director Sales
| PHCG Stock | USD 0 0.0002 10.00% |
Insider
Daniel Garza is Director Sales of Pure Harvest Cannabis
| Age | 38 |
| Phone | 800 924 3716 |
| Web | https://www.pureharvestgroup.com |
Pure Harvest Management Efficiency
The company has return on total asset (ROA) of (0.1726) % which means that it has lost $0.1726 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.858) %, meaning that it created substantial loss on money invested by shareholders. Pure Harvest's management efficiency ratios could be used to measure how well Pure Harvest manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Kevin MacDermott | cbdMD Inc | 62 | |
| David Erickson | Evolus Inc | N/A | |
| BComm BCom | Akanda Corp | 68 | |
| BCom BAcc | Akanda Corp | 44 | |
| Matthew Coapman | cbdMD Inc | 48 | |
| Tejinder Virk | Akanda Corp | 42 | |
| Erica CPA | Biofrontera | 39 | |
| Alex Dasalla | Collegium Pharmaceutical | N/A | |
| Hermann Lubbert | Biofrontera | 68 | |
| OriMoni Mimon | INC Research Holdings | 36 | |
| CCFP DipSportMed | Evolus Inc | 60 | |
| Amos Cohen | INC Research Holdings | 45 | |
| Jeff Holm | Biofrontera | N/A | |
| Elizabeth JD | ANI Pharmaceuticals | N/A | |
| Mark Baldyga | Biofrontera | N/A | |
| Raymond Coffman | cbdMD Inc | 62 | |
| Richard MD | Collegium Pharmaceutical | 64 | |
| Marlo Manning | Collegium Pharmaceutical | N/A | |
| Scott Sudduth | Collegium Pharmaceutical | N/A | |
| Eugene III | Biofrontera | 39 | |
| Muthusamy RPh | ANI Pharmaceuticals | 56 | |
Management Performance
| Return On Equity | -3.86 | |||
| Return On Asset | -0.17 |
Pure Harvest Cannabis Leadership Team
Elected by the shareholders, the Pure Harvest's board of directors comprises two types of representatives: Pure Harvest inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pure. The board's role is to monitor Pure Harvest's management team and ensure that shareholders' interests are well served. Pure Harvest's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pure Harvest's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peyton Bowman, Chief Officer | ||
| James MD, Chief Advisor | ||
| Donald Emmi, Director Kitchen | ||
| Sherry Andersen, Director Communications | ||
| Neale BS, Chief Cannabis | ||
| Matthew Gregarek, Chairman CEO | ||
| Nick Brait, G Counsel | ||
| Amanda Bowman, Chief Kitchen | ||
| Daniel Garza, Director Sales |
Pure Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Pure Harvest a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.86 | |||
| Return On Asset | -0.17 | |||
| Profit Margin | (2.68) % | |||
| Operating Margin | (1.04) % | |||
| Current Valuation | 7.15 M | |||
| Shares Outstanding | 84.76 M | |||
| Shares Owned By Insiders | 11.23 % | |||
| Price To Book | 1.59 X | |||
| Price To Sales | 0.60 X | |||
| Revenue | 2.54 M |
Currently Active Assets on Macroaxis
Other Information on Investing in Pure Pink Sheet
Pure Harvest financial ratios help investors to determine whether Pure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pure with respect to the benefits of owning Pure Harvest security.